Results 291 to 300 of about 33,124 (331)

Left Atrial Appendage Closure Outcomes in Patients With Cancer at a Single Tertiary Center.

American Journal of Cardiology, 2023
Atrial fibrillation is the most common arrhythmia in patients with underlying malignancy. Patients with cancer have a higher risk of bleeding, and at the same time, carry an elevated risk of thromboembolism related to the hypercoagulable state, type of ...
Sundeep Kumar, S. Yoon, Ioannis Milioglou, N. Tashtish, I. Farmakis, L. Dallan, Akhil Mogalapalli, Mauricio Arruda, S. Filby   +8 more
semanticscholar   +1 more source

Pericardial Effusion After Left Atrial Appendage Closure: Timing, Predictors, and Clinical Impact.

JACC: Cardiovascular Interventions
BACKGROUND Pericardial effusion (PE) is the most common serious left atrial appendage closure (LAAC) complication, but its mechanisms, time course, and prognostic impact are poorly understood.
R. Galea, T. Bini, Juan Perich Krsnik, Mariama Touray, F. Temperli, M. Kassar, Athanasios Papadis, S. Gloeckler, N. Brugger, R. Madhkour, D. Seiffge, L. Roten, G. Siontis, D. Heg, Stephan Windecker, L. Räber   +15 more
semanticscholar   +1 more source

Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease
Background Percutaneous left atrial appendage closure (LAAC) has been suggested as an alternative to long‐term oral anticoagulation for nonvalvular atrial fibrillation, but comparative data remain scarce. We aimed to assess ischemic and bleeding outcomes
A. Oliva, A. Ioppolo, M. Chiarito, A. Cremonesi, A. Azzano, E. Miccichè, A. Mangiameli, Francesco Ariano, Giuseppe Ferrante, Bernhard Reimers, P. Garot, Nicolas Amabile, R. Mehran, Gianluigi Condorelli, G. Stefanini, Da-Hua Cao   +15 more
semanticscholar   +1 more source

Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Hypertrophic Cardiomyopathy Patients with Atrial Fibrillation.

Heart Rhythm
BACKGROUND Percutaneous left atrial appendage closure (LAAC) is an effective alternative strategy for stroke prevention in atrial fibrillation (AF) patients at high risk for bleeding with anticoagulation (AC).
A. Aglan, Ayman R. Fath, B. J. Maron, M. Maron, Anand Prasad, A. Almomani, Muhammad Hammadah, Matthew R. Reynolds, E. Rowin   +8 more
semanticscholar   +1 more source

Double device left atrial appendage closure

EuroIntervention, 2015
Percutaneous left atrial appendage (LAA) occlusion is an alternative to oral anticoagulation for the prevention of stroke in patients with non-valvular atrial fibrillation (NVAF). Due to the great anatomic variability of the LAA, complete closure may not always be obtained with a single device.
Guérios, Enio E, Gloekler, Steffen, Schmid, Michael, Khattab, Ahmed, Nietlispach, Fabian, Meier, Bernhard   +5 more
openaire   +2 more sources

Transition from WATCHMAN generation‐2.5 device to WATCHMAN FLX device for percutaneous left atrial appendage closure: Incidence and predictors of device‐related thrombosis and short‐ to mid‐term outcomes

Catheterization and cardiovascular interventions
Patients with nonvalvular atrial fibrillation (AF) not suitable for long‐term anticoagulant therapy undergo percutaneous left atrial appendage closure (LAAC) using the WATCHMAN device.
R. Chatani, Shunsuke Kubo, H. Tasaka, N. Nishiura, K. Mushiake, S. Ono, T. Maruo, K. Kadota   +7 more
semanticscholar   +1 more source

Novel percutaneous left atrial appendage closure

Cardiovascular Revascularization Medicine, 2013
The primary disease target for our innovation is thromboembolic stroke from AF. This disease is addressed by removing the LAA from the systemic circulation using a novel percutaneous epicardial transcatheter based solution. In addition to avoiding the morbidity of open heart surgery, this solution does not necessitate entering a cardiac chamber.
Charles J, Bruce, Samuel J, Asirvatham, Trevor, McCaw, Eliot, Hong, Steven, Berhow, Naser M, Ammash, Paul A, Friedman   +6 more
openaire   +2 more sources

Left Atrial Appendage Closure Device in Atrial Fibrillation

Cardiology Clinics, 2015
The relationship of stroke and atrial fibrillation seems to become more complex as we gain more knowledge of the issue. Recent studies have questioned the temporal relationship between the two, which also questions causation. Left atrial appendage closure is an attractive, but unproven technology when compared with the 50-year experience with warfarin.
Michael C, Giudici, Prashant D, Bhave
openaire   +3 more sources

An International Consensus Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician: Executive Summary

Thrombosis and Haemostasis
Many patients with atrial fibrillation (AF) who are in need of stroke prevention are not treated with oral anticoagulation or discontinue treatment shortly after its initiation.
Tatjana S. Potpara, M. Grygier, K. Haeusler, J. Nielsen-Kudsk, S. Berti, S. Genovesi, E. Marijon, S. Boveda, A. Tzikas, G. Boriani, L. Boersma, C. Tondo, T. Potter, G. Lip, Renate B. Schnabel, R. Bauersachs, Marco Senzolo, Carlo Basile, Stefano Bianchi, P. Osmančík, Boris Schmidt, U. Landmesser, W. Doehner, G. Hindricks, Jan Kovac, A. Camm   +25 more
semanticscholar   +1 more source

Left Atrial Appendage Closure

Cardiac Electrophysiology Clinics, 2020
Rodney P. Horton, Carola Gianni, Andrea Natale   +2 more
  +4 more sources